15 November, 2026

Two Leaking Valves, Two New Devices: HANCOR TAVR and NeoNova TEER for Pure AR and MR

Case Series · Concomitant TEER Procedures · Case 2

Two leaking valves, a patient considered high risk for open-heart surgery, and two new devices. This is how the team treated pure aortic regurgitation and significant mitral regurgitation in a single sitting, without opening the chest.

Dr A B Gopalamurugan · Interventional & Structural Heart Team · 6 min read
2 valvesAortic and mitral treated in one sitting
26 mmHANCOR valve for pure AR, sized on CT
1 claspNeoNova TEER, 6 mm wide × 10 mm long
India firstFirst NeoNova TEER device in India
1 The presentation

Two regurgitant valves and a high-risk surgical route

A 70-year-old patient with morbid obesity had significant aortic regurgitation (AR) and significant mitral regurgitation (MR), with a dilated, impaired left ventricle.

The surgical option was a big one: a Bentall procedure (the aorta measured 5 cm) together with mitral valve replacement. The patient was quoted high risk for surgery, decided against it and looked for alternatives.

On referral, the team offered TAVR, with or without TEER. The aortic valve would be treated first, and the mitral valve only if the MR was still significant on the table after TAVR.

Pure aortic regurgitationSignificant MRLV dilatation & impairmentAorta 5 cmHigh surgical risk
Baseline echo
Baseline colour Doppler. Regurgitant flow with a dilated left ventricle.
Baseline TEE
Aortic valve on TEE. Short-axis view with colour showing the aortic leak.
3D TEE
3D view used in planning.
Baseline TEE
The aortic regurgitant jet on colour Doppler.
Baseline TEE
Another view of the AR jet before treatment.

⚠️ Why pure AR is hard for TAVR: standard TAVR valves are usually anchored by calcium on a narrowed aortic valve. In pure aortic regurgitation there is often little or no calcium to grip, so a dedicated anchoring approach is needed.

2 Treating the aortic valve

HANCOR TAVR: dock first, then sandwich the leaflets

The patient had a horizontal aorta, which can make it harder to line up and position a transcatheter valve. A 26 mm HANCOR device was chosen according to CT sizing.

Step 1: deploy the sinus docksThe docks sit in the aortic sinuses, behind the native leaflets.
Step 2: deploy the valveThe valve is opened inside the docks so the native leaflets are sandwiched between the docks and the valve frame, which anchors it without relying on calcium.
Fluoroscopy
Setting up in the aortic root.
Fluoroscopy
Delivery system across a horizontal aorta.
Fluoroscopy
Valve deployment inside the docks.
Fluoroscopy
HANCOR valve in place.

“After the sinus docks were deployed, valve deployed to sandwich the leaflets between the dock and the valve.”Procedure note, Dr A B Gopalamurugan

3 The decision point

Was the MR still significant after TAVR?

Treating aortic regurgitation can sometimes reduce mitral regurgitation, because it lowers the volume load on the left ventricle. That is why the plan was to reassess on the table. Here, the MR was still significant after TAVR, so the team proceeded with TEER in the same sitting.

Post-TAVR TEE
The new aortic valve on TEE.
Post-TAVR TEE
Biplane view after TAVR.
Mitral reassessment
Significant MR remained after TAVR.
4 Treating the mitral valve

NeoNova TEER: India’s first

The significant MR was treated with the NeoNova TEER device, using a single clasp, 6 mm wide and 10 mm long. According to the team, this was the first NeoNova device used in India.

Like other TEER systems, it is delivered through a vein and across the heart’s inner wall to the mitral valve, where it grasps the two leaflets and holds them together to reduce the leak.

Biplane TEE
Lining up the device over the mitral leaflets.
Biplane TEE
Leaflet grasp under biplane guidance.
Biplane TEE
Checking leaflet insertion.
Colour Doppler
Colour check after the clasp is closed.
Colour Doppler
Assessing residual MR.
Fluoroscopy
TEER device under fluoroscopy.
Fluoroscopy
Clasp release.
Fluoroscopy
Final position: TAVR valve and TEER clasp together.
5 The bigger picture

What this case teaches

01High surgical risk doesn’t mean no options

When open surgery (Bentall plus MVR) carried high risk, a combined transcatheter approach still treated both valves.

02Pure AR needs a dedicated anchor

Sinus docks let the valve sandwich the native leaflets, giving a secure seat without calcium.

03Treat the aortic valve first, then reassess

Deciding on TEER on the table after TAVR avoids an unnecessary mitral procedure if the MR settles.

04New devices widen the toolkit

HANCOR and NeoNova add options for anatomy and pathology that older devices handled less well.

“Two not so uncommon scenarios where surgery was high risk where not so uncommon concomitant procedures with TEER provided a wholistic solution.”Dr A B Gopalamurugan

Two leaking valves? There may be a non-surgical path

Our structural heart team assesses patients with aortic and mitral regurgitation who are high risk for surgery, and plans combined transcatheter treatment where it fits.

Request a consultation

Previous in this series · Case 1Impella-Assisted PCI and TEER in Cardiogenic Shock →

This case is shared for medical education. Images and clips are de-identified procedural recordings. Individual outcomes vary, and treatment decisions should be made with your cardiologist.

Share